Fortis Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Fortis Capital Advisors's LLY Position: Q2 2026 in Review
Fortis Capital Advisors increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $487K and bringing the position to 3,684 shares worth $4.42M. The position accounts for 0.5% of the portfolio, ranked #35.
Fortis Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Fortis Capital Advisors held 3,684 shares of Eli Lilly worth $4.42M as of Q2 2026.
- Fortis Capital Advisors bought 477 Eli Lilly shares in Q2 2026, an estimated $487K.
- Eli Lilly made up 0.5% of Fortis Capital Advisors's portfolio in Q2 2026, its #35 holding.
- Fortis Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.